Press Releases Jaguar Health, Inc.

Equities

JAGX

US47010C8055

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-31 pm EDT			5-day change	1st Jan Change
4.22 ^USD	-1.63%		-8.86%	-53.54%

May. 30	Top Premarket Gainers	MT
May. 29	Jaguar Health Expands Out-licensing Agreement With Magdalena Biosciences	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Investigator-Initiated Trial of Jaguar Health's Crofelemer Yields Positive Results for Functional Diarrhea	May. 29	AQ
Jaguar Health Announces Reverse Stock Split	May. 20	AQ
Jaguar Health : Corporate Presentation – May 15, 2024	May. 15	PU
Jaguar Health to Hold Investor Webcast Tuesday, May 14th at 8:30 AM Eastern Regarding Q1 2024 Financials and Corporate Updates	May. 09	AQ
Napo Pharmaceuticals, a Jaguar Health Family Company, Sponsoring Pediatric Gastroenterology Conference in Abu Dhabi and Panel Discussion about Microvillus Inclusion Disease	Apr. 30	AQ
Napo Pharmaceuticals, a Jaguar Health Family Company, to Exhibit at Oncology Nursing Society Congress in Support of Company's Expanding Focus on Cancer Supportive Care	Apr. 23	AQ
Jaguar Health Appoints Biopharmaceutical Industry Veteran to Execute Company's In-licensing Growth Strategy in the Areas of Cancer and GI Supportive Care	Apr. 19	AQ
Jaguar Health Reports Approval of All Proposals at April 2024 Special Meeting of Stockholders	Apr. 10	AQ
Jaguar Health Granted Extension until August 13, 2024, to Regain Compliance with Nasdaq's Bid Price Requirement	Apr. 09	AQ
Jaguar Health : Corporate Presentation – April 1, 2024	Apr. 05	PU
Jaguar Health Appoints European Pharmaceutical Industry Leader as President of Jaguar International	Apr. 03	AQ
Jaguar Health Reports 2023 Financial Results	Apr. 02	AQ
Jaguar Health to Hold Investor Webcast Monday, April 1st at 8:30 AM Eastern Regarding Q4 2023 Financials and Corporate Updates	Mar. 28	AQ
Jaguar Health Requests and Receives Hearing on Nasdaq Listing Compliance	Feb. 26	AQ
Jaguar Health Donates Supply of Mytesi to Humanitarian Aid Organization Direct Relief	Feb. 15	AQ
Jaguar Health Announces Submission of Orphan Drug Designation Application to the FDA for Crofelemer for Cholera-Related Diarrhea	Feb. 13	AQ
Magdalena Biosciences, a Joint Venture between Jaguar Health and Filament Health, Study Indicates Psychoactive Activity of Medicinal Plant Utilized for Centuries by Indigenous Peoples in Tropical Regions	Jan. 31	AQ
Jaguar Health to Present January 31 at the Microcap Conference and Participate in a Fireside Chat February 1 at the Lytham Partners Investor Select Conference	Jan. 30	AQ
Dog Study Published in PLOS ONE Shows Statistically Significant Results for Use of Jaguar Health's Crofelemer for Preventive Treatment of Cancer Therapy-Related Diarrhea	Jan. 26	AQ
Jaguar Health : Corporate Presentation – December 11, 2023	Dec. 19	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Jaguar Health, Inc.

Equities

JAGX

US47010C8055

Press Releases

Filters